HUP0003074A3 - Pharmaceutical composition comprising ssri and betha-blocking agent - Google Patents
Pharmaceutical composition comprising ssri and betha-blocking agentInfo
- Publication number
- HUP0003074A3 HUP0003074A3 HU0003074A HUP0003074A HUP0003074A3 HU P0003074 A3 HUP0003074 A3 HU P0003074A3 HU 0003074 A HU0003074 A HU 0003074A HU P0003074 A HUP0003074 A HU P0003074A HU P0003074 A3 HUP0003074 A3 HU P0003074A3
- Authority
- HU
- Hungary
- Prior art keywords
- betha
- ssri
- pharmaceutical composition
- blocking agent
- blocking
- Prior art date
Links
- 239000002981 blocking agent Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9714675.7A GB9714675D0 (en) | 1997-07-11 | 1997-07-11 | Novel composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0003074A2 HUP0003074A2 (en) | 2001-01-29 |
| HUP0003074A3 true HUP0003074A3 (en) | 2001-12-28 |
Family
ID=10815744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0003074A HUP0003074A3 (en) | 1997-07-11 | 1998-07-07 | Pharmaceutical composition comprising ssri and betha-blocking agent |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0996466A2 (en) |
| JP (1) | JP2002508003A (en) |
| KR (1) | KR20010021644A (en) |
| CN (1) | CN1262627A (en) |
| AP (1) | AP2000001728A0 (en) |
| AR (1) | AR016128A1 (en) |
| AU (1) | AU9340198A (en) |
| BG (1) | BG104119A (en) |
| BR (1) | BR9810996A (en) |
| CA (1) | CA2295822A1 (en) |
| CO (1) | CO4950552A1 (en) |
| DZ (1) | DZ2556A1 (en) |
| EA (1) | EA200000112A1 (en) |
| GB (1) | GB9714675D0 (en) |
| HU (1) | HUP0003074A3 (en) |
| ID (1) | ID24191A (en) |
| IL (1) | IL133869A0 (en) |
| MA (1) | MA24604A1 (en) |
| NO (1) | NO20000107L (en) |
| OA (1) | OA11276A (en) |
| PE (1) | PE99699A1 (en) |
| PL (1) | PL338017A1 (en) |
| SK (1) | SK72000A3 (en) |
| TR (1) | TR200000074T2 (en) |
| WO (1) | WO1999002142A2 (en) |
| ZA (1) | ZA986138B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000021509A2 (en) | 1998-10-15 | 2000-04-20 | Imperial College Innovations Limited | Methods of treatment |
| PL205109B1 (en) | 1998-11-02 | 2010-03-31 | Elan Pharma Int Ltd | Multiparticulate modified release composition |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| IL149352A0 (en) | 1999-10-29 | 2002-11-10 | Euro Celtique Sa | Controlled release hydrocodone formulations |
| GB0004003D0 (en) * | 2000-02-22 | 2000-04-12 | Knoll Ag | Therapeutic agents |
| EP2295042A1 (en) | 2000-10-30 | 2011-03-16 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
| JP2008513430A (en) * | 2004-09-17 | 2008-05-01 | ニューロキュア リミテッド | Pindolol for the treatment of premenstrual syndrome and premenstrual dysphoric disorder |
| CN100469356C (en) * | 2006-09-08 | 2009-03-18 | 山东益康药业有限公司 | Slowly released tablet of compound atenolol, and preparation method |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2732335C2 (en) * | 1976-07-27 | 1983-01-20 | Sandoz-Patent-GmbH, 7850 Lörrach | Tablet for the enteral administration of indolyloxyalkanolamine derivatives |
| CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug response by a serotonin 1A receptor antagonist |
| EP0759299B1 (en) * | 1995-08-16 | 2000-04-26 | Eli Lilly And Company | Potentiation of serotonin response |
| EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
-
1997
- 1997-07-11 GB GBGB9714675.7A patent/GB9714675D0/en active Pending
-
1998
- 1998-07-07 EP EP98946294A patent/EP0996466A2/en not_active Withdrawn
- 1998-07-07 AU AU93401/98A patent/AU9340198A/en not_active Abandoned
- 1998-07-07 SK SK7-2000A patent/SK72000A3/en unknown
- 1998-07-07 PL PL98338017A patent/PL338017A1/en unknown
- 1998-07-07 TR TR2000/00074T patent/TR200000074T2/en unknown
- 1998-07-07 HU HU0003074A patent/HUP0003074A3/en unknown
- 1998-07-07 CN CN98806975A patent/CN1262627A/en active Pending
- 1998-07-07 BR BR9810996-0A patent/BR9810996A/en not_active Application Discontinuation
- 1998-07-07 AP APAP/P/1999/001728A patent/AP2000001728A0/en unknown
- 1998-07-07 CA CA002295822A patent/CA2295822A1/en not_active Abandoned
- 1998-07-07 WO PCT/EP1998/004971 patent/WO1999002142A2/en not_active Application Discontinuation
- 1998-07-07 IL IL13386998A patent/IL133869A0/en unknown
- 1998-07-07 ID IDW20000035A patent/ID24191A/en unknown
- 1998-07-07 KR KR1020007000202A patent/KR20010021644A/en not_active Application Discontinuation
- 1998-07-07 JP JP50818599A patent/JP2002508003A/en active Pending
- 1998-07-07 EA EA200000112A patent/EA200000112A1/en unknown
- 1998-07-08 DZ DZ980166A patent/DZ2556A1/en active
- 1998-07-10 PE PE1998000612A patent/PE99699A1/en not_active Application Discontinuation
- 1998-07-10 MA MA25165A patent/MA24604A1/en unknown
- 1998-07-10 CO CO98039260A patent/CO4950552A1/en unknown
- 1998-07-10 ZA ZA9806138A patent/ZA986138B/en unknown
- 1998-07-10 AR ARP980103371A patent/AR016128A1/en unknown
-
2000
- 2000-01-10 NO NO20000107A patent/NO20000107L/en not_active Application Discontinuation
- 2000-01-11 OA OA1200000006A patent/OA11276A/en unknown
- 2000-02-01 BG BG104119A patent/BG104119A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0003074A2 (en) | 2001-01-29 |
| EP0996466A2 (en) | 2000-05-03 |
| ID24191A (en) | 2000-07-13 |
| AU9340198A (en) | 1999-02-08 |
| NO20000107D0 (en) | 2000-01-10 |
| KR20010021644A (en) | 2001-03-15 |
| DZ2556A1 (en) | 2003-02-15 |
| MA24604A1 (en) | 1999-04-01 |
| BR9810996A (en) | 2000-08-08 |
| GB9714675D0 (en) | 1997-09-17 |
| JP2002508003A (en) | 2002-03-12 |
| CN1262627A (en) | 2000-08-09 |
| SK72000A3 (en) | 2000-12-11 |
| ZA986138B (en) | 2000-01-10 |
| CO4950552A1 (en) | 2000-09-01 |
| WO1999002142A3 (en) | 1999-04-15 |
| AR016128A1 (en) | 2001-06-20 |
| TR200000074T2 (en) | 2000-05-22 |
| IL133869A0 (en) | 2001-04-30 |
| NO20000107L (en) | 2000-01-10 |
| OA11276A (en) | 2003-07-31 |
| EA200000112A1 (en) | 2000-10-30 |
| PE99699A1 (en) | 1999-12-21 |
| CA2295822A1 (en) | 1999-01-21 |
| AP2000001728A0 (en) | 2000-03-31 |
| WO1999002142A2 (en) | 1999-01-21 |
| PL338017A1 (en) | 2000-09-25 |
| BG104119A (en) | 2000-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0004318A3 (en) | Pharmaceutical composition comprising atorvastatin and an antihypertensive agent | |
| IL123986A0 (en) | Antithombotic agents process for their preparation and pharmaceutical compositions comprising them | |
| HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
| HUP0200548A2 (en) | Pharmaceutical compositions and their use | |
| HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
| IL135646A0 (en) | α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
| HUP0100149A3 (en) | Antipicornaviral peptide derivatives pharmaceutical compositions comprising thereof and their use | |
| IL136251A0 (en) | Soft pellet drug composition and methods for the preparation thereof | |
| PL335555A1 (en) | Novel compounds - substituted benzamides and therapeutic agent | |
| HK1033653A1 (en) | Synergistic composition and use thereof | |
| IL133097A0 (en) | Aroyl-piperazine derivatives pharmaceutical compositions containing the same and the use thereof | |
| IL123927A (en) | Propanolamine derivatives processes for their preparation and pharmaceutical composition comprising them | |
| HUP9802132A3 (en) | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them | |
| HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them | |
| HUP0101701A3 (en) | Substituted betha-alanines and pharmaceutical compositions comprising them | |
| HUP0002331A3 (en) | 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof | |
| HUP0003189A3 (en) | Pharmaceutical composition comprising fexofenadine and its derivatives | |
| HUP0101733A3 (en) | Pharmaceutical compositions containing sulfonyl-dipeptides and their use | |
| HUP0004223A3 (en) | 4-oxo-butynic acids and pharmaceutical composition containing them as active agent | |
| IL140742A0 (en) | Raloxifene and pharmaceutical composition comprising the same | |
| IL125908A (en) | Peptides and pharmaceutical compositions comprising same | |
| HUP0000460A3 (en) | Imidazopyridazines and pharmaceutical compositions thereof | |
| HUP0003074A3 (en) | Pharmaceutical composition comprising ssri and betha-blocking agent | |
| HUP9802590A3 (en) | Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them | |
| EP0987942A4 (en) | Pharmaceutical composition and methods for using it |